These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36805331)

  • 1. Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV.
    Schnittman SR; Jung W; Fitch KV; Zanni MV; McCallum S; Lee JS; Shin S; Davis BJ; Fulda ES; Diggs MR; Giguel F; Chinchay R; Sheth AN; Fichtenbaum CJ; Malvestutto C; Aberg JA; Currier J; Lauffenburger DA; Douglas PS; Ribaudo HJ; Alter G; Grinspoon SK
    JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36805331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.
    Verburgh ML; van Pul L; Grobben M; Boyd A; Wit FWNM; van Nuenen AC; van Dort KA; Tejjani K; van Rijswijk J; Bakker M; van der Hoek L; Schim van der Loeff MF; van der Valk M; van Gils MJ; Kootstra NA; Reiss P
    Microbiol Spectr; 2023 Jun; 11(3):e0115523. PubMed ID: 37166335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.
    Peluso MJ; Spinelli MA; Deveau TM; Forman CA; Munter SE; Mathur S; Tang AF; Lu S; Goldberg SA; Arreguin MI; Hoh R; Tai V; Chen JY; Martinez EO; Yee BC; Chenna A; Winslow JW; Petropoulos CJ; Sette A; Weiskopf D; Kumar N; Lynch KL; Hunt PW; Durstenfeld MS; Hsue PY; Kelly JD; Martin JN; Glidden DV; Gandhi M; Deeks SG; Rutishauser RL; Henrich TJ
    AIDS; 2022 Oct; 36(12):F7-F16. PubMed ID: 35866847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
    Overton ET; Weir IR; Zanni MV; Fischinger S; MacArthur RD; Aberg JA; Fitch KV; Frank M; Albrecht H; Goodenough E; Rhame FS; Fichtenbaum CJ; Bloomfield GS; Malvestutto C; Supparatpinyo K; McCallum S; Douglas PS; Alter G; Ribaudo H; Grinspoon SK
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):377-381. PubMed ID: 35413022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution.
    Benet S; Blanch-Lombarte O; Ainsua-Enrich E; Pedreño-Lopez N; Muñoz-Basagoiti J; Raïch-Regué D; Perez-Zsolt D; Peña R; Jiménez E; Rodríguez de la Concepción ML; Ávila C; Cedeño S; Escribà T; Romero-Martín L; Alarcón-Soto Y; Rodriguez-Lozano GF; Miranda C; González S; Bailón L; Blanco J; Massanella M; Brander C; Clotet B; Paredes R; Esteve M; Izquierdo-Useros N; Carrillo J; Prado JG; Moltó J; Mothe B
    J Infect Dis; 2022 Nov; 226(11):1913-1923. PubMed ID: 36200261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH).
    Tuan JJ; Zapata H; Barakat L; Andrews L; Behnegar A; Kim YW; Kayani J; Mutic S; Ryall L; Turcotte B; Critch-Gilfillan T; Zhao M; Salahuddin S; Gupta S; Sutton R; Friedland G; Emu B; Ogbuagu O
    BMC Infect Dis; 2022 Sep; 22(1):744. PubMed ID: 36131232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response to SARS-CoV-2 in people with HIV.
    Höft MA; Burgers WA; Riou C
    Cell Mol Immunol; 2024 Feb; 21(2):184-196. PubMed ID: 37821620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy.
    Jedicke N; Stankov MV; Cossmann A; Dopfer-Jablonka A; Knuth C; Ahrenstorf G; Ramos GM; Behrens GMN
    HIV Med; 2022 May; 23(5):558-563. PubMed ID: 34725907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection.
    Augello M; Bono V; Rovito R; Tincati C; d'Arminio Monforte A; Marchetti G
    AIDS; 2023 Aug; 37(10):1503-1517. PubMed ID: 37199415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV.
    Donadeu L; Tiraboschi JM; Scévola S; Torija A; Meneghini M; Jouve T; Favà A; Calatayud L; Ardanuy C; Cidraque I; Preyer R; Strecker K; Lozano JJ; Podzamczer D; Crespo E; Bestard O
    AIDS; 2022 Aug; 36(10):1373-1382. PubMed ID: 35730384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count.
    Antinori A; Cicalini S; Meschi S; Bordoni V; Lorenzini P; Vergori A; Lanini S; De Pascale L; Matusali G; Mariotti D; Cozzi Lepri A; Gallì P; Pinnetti C; Gagliardini R; Mazzotta V; Mastrorosa I; Grisetti S; Colavita F; Cimini E; Grilli E; Bellagamba R; Lapa D; Sacchi A; Marani A; Cerini C; Candela C; Fusto M; Puro V; Castilletti C; Agrati C; Girardi E; Vaia F;
    Clin Infect Dis; 2022 Aug; 75(1):e552-e563. PubMed ID: 35366316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Human Immunodeficiency Virus Viremia and Compromised Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant.
    Hwa SH; Snyman J; Bernstein M; Ganga Y; Cele S; Muema D; Tan CW; Khan K; Karim F; Hanekom W; Bernstein L; Kaufmann SHE; Wang LF; Ndung'u T; Sigal A;
    J Infect Dis; 2023 Jan; 227(2):211-220. PubMed ID: 35975942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2.
    Pourcher V; Belin L; Soulie C; Rosenzwajg M; Marot S; Lacombe K; Valin N; Pialoux G; Calin R; Palacios C; Malet I; Zafilaza K; Tubiana R; Valantin MA; Klatzmann D; Calvez V; Simon-Tillaux N; Marcelin AG
    AIDS; 2022 Sep; 36(11):1545-1552. PubMed ID: 35730380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
    Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
    HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center.
    Friedman EE; Devlin SA; McNulty MC; Ridgway JP
    PLoS One; 2021; 16(7):e0254994. PubMed ID: 34288954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people with HIV.
    Casado JL; Vizcarra P; Martín-Colmenarejo S; Del Pino J; Gomez-Maldonado S; Martín-Hondarza A; Vallejo A
    AIDS; 2023 May; 37(6):877-882. PubMed ID: 36779501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.
    Del Amo J; Polo R; Moreno S; Jarrín I; Hernán MA
    AIDS; 2022 Feb; 36(2):161-168. PubMed ID: 34934017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy.
    Cheung PK; Lapointe HR; Sang Y; Ennis S; Mwimanzi F; Speckmaier S; Barad E; Dong W; Liang R; Simons J; Lowe CF; Romney MG; Brumme CJ; Niikura M; Brockman MA; Brumme ZL;
    AIDS; 2023 Apr; 37(5):F11-F18. PubMed ID: 36789806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Longitudinal Analysis of SARS-CoV-2 Antibody Responses Among People With HIV.
    Alcaide ML; Nogueira NF; Salazar AS; Montgomerie EK; Rodriguez VJ; Raccamarich PD; Barreto IT; McGaugh A; Sharkey ME; Mantero AM; Rodriguez AE; Beauchamps L; Jones DL
    Front Med (Lausanne); 2022; 9():768138. PubMed ID: 35330585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.